Triple Therapy in Asthma - Your Questions Answered

Trending3.5(New)

Asthma is a chronic respiratory condition characterised by airway inflammation, bronchoconstriction, and airway hyperresponsiveness. While most patients achieve control with standard therapies such as inhaled corticosteroids (ICS) combined with long‑acting beta‑agonists (LABA), a subset of individuals with moderate to severe disease continue to experience symptoms and exacerbations despite appropriate treatment. For these patients, guideline‑informed step‑up therapy may include adding a long‑acting muscarinic antagonist (LAMA) to their regimen—creating what is known as triple therapy (ICS + LABA + LAMA). Triple therapy aims to provide broader bronchodilation and enhanced anti‑inflammatory effects, targeting different pathways within the airway.

7 Modules1 hour
$169$0
Start Learning
Triple Therapy in Asthma - Your Questions Answered

Learning Outcomes

What you'll learn

  • Describe the components and mechanisms of triple therapy in asthma.
  • Identify appropriate clinical indications for triple therapy.
  • Assess patient suitability for step‑up to triple therapy.
  • Implement triple therapy with attention to inhaler technique and adherence.
  • Monitor treatment efficacy and adjust therapy based on clinical response.
  • Counsel patients effectively about expected benefits, risks, and correct inhaler use.

Stay updated with our

Healthcare trainingHealthcare training

Training Overview

  • What is Triple Therapy in Asthma?
  • When to Consider Triple Therapy
  • Evidence and Outcomes with Triple Therapy
  • Implementing Triple Therapy in Practice
  • Monitoring and Adjusting Triple Therapy
  • Patient Education and Shared Decision‑Making
  • Summary
Healthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare training

Top reviews

No reviews yet.

You May Also Like

Take Your
Learning Anywhere

Stay on top of your learning with the Care Learning app.

Download on the App StoreGet it on Google Play

Are you a qualified
Trainer or Instructor?

Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.

Refer a Friend &
Earn Rewards.

Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.

1 / 3

Frequently asked questions

A maintenance regimen combining an inhaled corticosteroid (ICS), long‑acting beta‑agonist (LABA), and long‑acting muscarinic antagonist (LAMA).

When asthma is not controlled with medium‑ or high‑dose ICS/LABA despite good adherence.

Yes, single‑inhaler triple combinations are available and may improve adherence.

Improved lung function and reduced exacerbations in selected patients.

No. It’s a step‑up option after dual therapy is insufficient.

Proper technique ensures optimal drug delivery and therapeutic effect.